Tumor Junction Burden and Antigen Presentation as Predictors of Survival in Mesothelioma Treated With Immune Checkpoint Inhibitors

January 3, 2022 | Comments Off on Tumor Junction Burden and Antigen Presentation as Predictors of Survival in Mesothelioma Treated With Immune Checkpoint Inhibitors

Journal of Thoracic Oncology 2021 November 17 [Link] Farhad Kosari, Maria Disselhorst, Jun Yin, Tobias Peikert, Julia Udell, Sarah Johnson, James Smadbeck, Stephen Murphy, Alexa McCune, Giannoula Karagouga, Aakash Desai,…

BRCA-associated protein 1 (BAP1) and miR-31 combination predicts outcomes in epithelioid malignant pleural mesothelioma

December 17, 2021 | Comments Off on BRCA-associated protein 1 (BAP1) and miR-31 combination predicts outcomes in epithelioid malignant pleural mesothelioma

Journal of Thoracic Disease 2021 October [Link] Albero Murrone, Luca Cantini, Federica Pecci, Valeria Cognigni, Cecilia Copparoni, Silvia Rinaldi, Ilaria Fiordoliva, Federica Monaco, Corrado Rubini, Francesca Barbisan, Alessia Cimadamore, Riccardo…

Cytological Diagnostic Procedures in Malignant Mesothelioma

December 16, 2021 | Comments Off on Cytological Diagnostic Procedures in Malignant Mesothelioma

Advances in Experimental Medicine and Biology 2021 November 18 [Link] Christian Biancosino, Lea Isabell Shari van der Linde, Guido Sauter, Florian Stellmacher, Marcus Krüger, Lutz Welker Abstract Malignant mesotheliomas (MM)…

Correlation between immune-related adverse events and therapeutic effects of nivolumab in patients with malignant pleural mesothelioma

December 15, 2021 | Comments Off on Correlation between immune-related adverse events and therapeutic effects of nivolumab in patients with malignant pleural mesothelioma

BMC Pulmonary Medicine 2021 November 15 [Link] Hiroto Yoneda, Hiroshi Nokihara, Atsushi Mitsuhashi, Ryohiko Ozaki, Yohei Yabuki, Hirokazu Ogino, Kenji Otsuka, Yasuhiko Nishioka Abstract Background: Nivolumab is used for the…

Assessment of Risk of Hereditary Predisposition in Patients With Melanoma and/or Mesothelioma and Renal Neoplasia

December 14, 2021 | Comments Off on Assessment of Risk of Hereditary Predisposition in Patients With Melanoma and/or Mesothelioma and Renal Neoplasia

JAMA Network Open 2021 November 1 [Link] Sounak Gupta 1, Lori A Erickson, Christine M Lohse, Wei Shen, Beth A Pitel, Shannon M Knight, Kevin C Halling, Loren Herrera-Hernandez, Stephen…

MALAT1 promotes malignant pleural mesothelioma by sponging miR-141-3p

December 13, 2021 | Comments Off on MALAT1 promotes malignant pleural mesothelioma by sponging miR-141-3p

Open Medicine 2021 November 3 [Link] Pei Wang, Cuiwei Bai, Shasha Shen, Chang Jiang, Jie Deng, Dan Han Abstract The aim of this study was to clarify the role of…

ATG7 immunohistochemical expression in Malignant Pleural Mesothelioma. A preliminary report

December 10, 2021 | Comments Off on ATG7 immunohistochemical expression in Malignant Pleural Mesothelioma. A preliminary report

Histology and Histopathology 2021 November 11 [Link] Venerando Rapisarda, Giuseppe Broggi, Rosario Caltabiano, Claudia Lombardo, Sergio Castorina, Angela Trovato, Caterina Ledda, Veronica Filetti, Carla Loreto Abstract Literature evidence has demonstrated…

Durvalumab with platinum-pemetrexed for unresectable pleural mesothelioma: survival, genomic and immunologic analyses from the phase 2 PrE0505 trial

December 9, 2021 | Comments Off on Durvalumab with platinum-pemetrexed for unresectable pleural mesothelioma: survival, genomic and immunologic analyses from the phase 2 PrE0505 trial

Nature Medicine 2021 November [Link] Patrick M Forde, Valsamo Anagnostou, Zhuoxin Sun, Suzanne E Dahlberg, Hedy L Kindler, Noushin Niknafs, Thomas Purcell, Rafael Santana-Davila, Arkadiusz Z Dudek, Hossein Borghaei, Mara…

Histology of the pleural rind at [ 18 F]FDG PET/CT hot and cold spots in mesothelioma patients after talc pleurodesis and neoadjuvant chemotherapy

December 8, 2021 | Comments Off on Histology of the pleural rind at [ 18 F]FDG PET/CT hot and cold spots in mesothelioma patients after talc pleurodesis and neoadjuvant chemotherapy

Pathology, Research and Practice 2021 December [Link] Alex Soltermann, Isabelle Opitz, Irene A Burger Abstract The role of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/computed tomography ([18F]FDG PET/CT) in evaluating induction chemotherapy in…

Highly sensitive quantification of pemetrexed in human plasma using UPLC-MS/MS to support microdosing studies

December 7, 2021 | Comments Off on Highly sensitive quantification of pemetrexed in human plasma using UPLC-MS/MS to support microdosing studies

Biomedical Chromatography 2021 November 5 [Link] Eleonora W J van Ewijk-Beneken Kolmer, Marga J A Teulen, Rene J Boosman, Nikki de Rouw, Jacobus A Burgers, Rob Ter Heine Abstract Pemetrexed…

Categories